Metavention logo
Healthcare & Life Sciences

Metavention

Metavention is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.

Activeseries-c-plus
series-c-plus
Stage
1
Investors

About Metavention

Based in the United States, Metavention is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Metavention develops the iRF Denervation System, a minimally invasive radiofrequency-based medical device designed to disrupt overactive renal sympathetic nerves to treat high blood pressure and associated metabolic diseases. The device is currently in clinical studies and remains investigational under US federal law.

Explore Metavention's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States